Topline Pharma giant Pfizer on Tuesday said it would ask regulators to greenlight a vaccine designed to protect infants against respiratory syncytial virus, or RSV, following strong results in late-st...
Topline Pharma giant Pfizer on Tuesday said it would ask regulators to greenlight a vaccine designed to protect infants against respiratory syncytial virus, or RSV, following strong results in late-st...